Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia

Cancer Letters

Volumn 191, Issue 2, 2003, Pages 187-191

  Lambropoulos, A F ^a   Agorastos, T ^b   Foka, Z J ^a   Chrisafi, S ^a   Constantinidis, T C ^c   Bontis, J ^b   Kotsis, A ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Cervical cancer; Cervical neoplasia; Methylenetetrahydrofolate reductase; MTHFR C677T polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADULT; ARTICLE; CANCER RISK; COLPOSCOPY; CONTROLLED STUDY; CYTOLOGY; ENZYME POLYMORPHISM; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA;

EID: 0344642945     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00675-4     Document Type: Article

References (25)

1. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., Boers G.J., den Heijer M., Kluijtmans L.A., van den Heuvel L.P., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet. 10:1995;111-113.
2. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb. Haemost. 78:1997;523-526.
3. Ma J., Stampfer M.J., Giovannucci E., Artigas C., Hunter D.J., Fuchs C., Willett W.C., Selhub J., Hennekens C.H., Rozen R. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 57:1997;1098-1102.
4. Kim Y.I. Folate and cancer prevention: a new medical application of folate beyond hyperhomocysteinemia and neural tube defects. Nutr. Rev. 57:1999;314-321.
5. Duthie S.J. Folic acid deficiency and cancer: mechanisms of DNA instability. Br. Med. Bull. 55:1999;578-592.
6. Sharp L., Little J., Schofield A.C., Pavlidou E., Cotton S.C., Miedzybrodzka Z., Baird J.O.C., Haites N.E., Heys S.D., Grubb D.A. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett. 181:2002;65-71.
7. Piyathilake C.J., Macaluso M., Johanning G.L., Whiteside M., Heimburger D.C., Giuliano A. Methylenetetrahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res. 20:2000;1751-1757.
8. Goodman M.T., McDuffie K., Hernandez B., Wilkens L.R., Bertram C.C., Killeen J., Le Marchand L., Selhub J., Murphy S., Donlon T.A. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia. Cancer Epidemiol. Biomarkers Prev. 10:2001;1275-1280.
9. Kluijtmans L.A., den Heijer M., Reitsma P.H., Heil S.G., Blom H.J., Rosendaal F.R. Thermolabile methylenetetrahydrofolate reductase and factor V Leiden in the risk of deep-vein thrombosis. Thromb. Haemost. 79:1998;254-258.
10. Lange K. Basic principles in population genetics. Mathematical and Statistical Methods for Genetic Analysis. 1997;Springer, Heidelberg.
11. Shen H., Xu Y., Zheng Y., Qian Y., Yu R., Qin Y., Wang X., Spitz M.R., Wei Q. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer. 95:2001;332-336.
12. Ryan B.M., Weir D.G. Relevance of folate metabolism in the pathogenesis of colorectal cancer. J. Lab. Clin. Med. 138:2001;164-176.
13. Gershoni-Baruch R., Dagan E., Israeli D., Kasinetz L., Kadouri E., Friedman E. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur. J. Cancer. 36:2000;2313-2316.
14. Gonzalez Ordonez A.J., Fernandez Carreira J.M., Fernandez Alvarez C.R., Martin L., Sanchez Garcia J., Medina Rodriguez J.M., Alvarez M.V., Coto E. Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among lymphoproliferative disorders but not in multiple myeloma. Leuk. Lymphoma. 39:2000;607-612.
15. Gonzalez-Fraile M.I., Garcia-Sanz R., Mateos M.V., Balanzategui A., Gonzalez M., Vaquez L., San Miguel J.F. Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis. Br. J. Haematol. 117:2002;890-892.
16. Chen J., Giovannucci E., Kelsey K., Bimm E.B., Stampfer M.J., Colditz G.A., Spiegelman D., Willett W.C., Junter D.J. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res. 56:1996;4862-4864.
17. Ulrich C.M., Kampman E., Bigler J., Schwartz S.M., Chen C., Bostick R., Fosdick L., Beresford S.A., Yasui Y., Potter J.D. Lack of association between the C677T MTHFR polymorphism and colorectal hyperplastic polyps. Cancer Epidemiol. Biomarkers Prev. 9:2000;427-433.
18. Franco R.F., Simoes B.P., Tone L.G., Gabellini S.M., Zago M.A., Falcao R.P. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br. J. Haematol. 115:2001;616-618.
19. Skibola C.G., Smith M.T., Kane E., Roman E., Rollinson S., Cartwright R.A., Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl. Acad. Sci. USA. 96:1999;12810-12815.
20. Ulvik A., Evensen E.T., Lien E.A., Hoff G., Vollset S.E., Majak B.M., Ueland P.M. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am. J. Med. Genet. 101:2001;246-254.
21. Shen H., Spitz M.R., Wang L.E., Hong W.K., Wei Q. Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol. Biomarkers Prev. 10:2001;397-401.
22. Weinstein S.J., Gridley G., Harty L.C., Diehl S.R., Brown L.M., Winn D.M., Bravo-Otero E., Hayes R.B. Folate intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J. Nutr. 132:2002;762-767.
23. van der Put N.M., Steegers-Theunissen R.P., Frosst P., Trijbels F.J., Eskes T.K., van den Heuvel L.P., Mariman E.C., den Heyer M., Rozen R., Blom H.J. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet. 346:1995;1070-1071.
24. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., Malinow M.R., Willett W.C., Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 94:1996;2410-2416.
25. Foka Z.J., Lambropoulos A.F., Saravellos H., Karas G.B., Karavida A., Agorastos T., Zournatzi V., Makris P.E., Bontis J., Kotsis A. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages. Hum. Reprod. 15:2000;458-462.